Back
Spero Therapeutics Stock Price Chart
Sponsored
SPRO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
SPRO
Spero Therapeutics
Last Price:
1.12
Seasonality Move:
7.16%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing slight selling pressure.
Spero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Sell |
20-day SMA: | 1.24 | Sell |
50-day SMA: | 1.27 | Sell |
200-day SMA: | 1.43 | Sell |
8-day EMA: | 1.18 | Sell |
20-day EMA: | 1.22 | Sell |
50-day EMA: | 1.26 | Sell |
200-day EMA: | 1.37 | Sell |
Spero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -27946 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.18 - 1.32) | Sell |
Bollinger Bands (100): | (1.24 - 1.38) | Sell |
Spero Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spero Therapeutics Stock
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.13 while SPRO 8-day simple moving average is 1.16, which is a Sell signal.
- The stock price of SPRO is 1.13 while Spero Therapeutics 20-day SMA is 1.24, which makes it a Sell.
- Spero Therapeutics 50-day simple moving average is 1.27 while SPRO share price is 1.13, making it a Sell technically.
- SPRO stock price is 1.13 and Spero Therapeutics 200-day simple moving average is 1.43, creating a Sell signal.
SPRO Technical Analysis vs Fundamental Analysis
Sell
13
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a Sell
The current Spero Therapeutics [SPRO] share price is $1.13. The Score for SPRO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Spero Therapeutics Stock Info
Market Cap:
61.61M
Price in USD:
1.13
Share Volume:
195.62K
Spero Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
1.01
Sell
13
Spero Therapeutics (SPRO)
is a Sell
Spero Therapeutics Share Price Forecast
-
What is the Spero Therapeutics stock price today?
The Spero Therapeutics stock price is 1.13 USD today. -
Will SPRO stock go up or go down?
Spero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spero Therapeutics is overvalued.
Is Spero Therapeutics Stock a Buy?
- Spero Therapeutics share price is 1.13 while SPRO 8-day exponential moving average is 1.18, which is a Sell signal.
- The stock price of SPRO is 1.13 while Spero Therapeutics 20-day EMA is 1.22, which makes it a Sell.
- Spero Therapeutics 50-day exponential moving average is 1.26 while SPRO share price is 1.13, making it a Sell technically.
- SPRO stock price is 1.13 and Spero Therapeutics 200-day simple moving average is 1.37, creating a Sell signal.
Fundamental Analysis of Spero Therapeutics
Is Spero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.
Technical Analysis of Spero Therapeutics
Should I short Spero Therapeutics stock?
- SPRO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Spero Therapeutics is a Sell
- Spero Therapeutics Relative Strength Index (RSI) is 35.13, which suggest Spero Therapeutics is oversold
- The Bollinger Bands (25) for Spero Therapeutics is (1.18 - 1.32), which suggest Spero Therapeutics is a Sell
- The Bollinger Bands (100) for Spero Therapeutics is (1.24 - 1.38), which suggest Spero Therapeutics is a Sell
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.